Table 4.
Demographic and laboratory results of the subclinical hypothyroid and euthyroid Hashimoto patients.
| Subclinical hypothyroid n = 50 |
Euthyroid Hashimoto n = 56 |
P | |
|---|---|---|---|
| Age (mean ± SD) |
36.80 ± 8.19 | 36.3 ± 8.11 | 0.76 |
|
| |||
| TSH (mIU/mL) | 7.25 [IQR: 5.94–8.61] |
2.39 [IQR: 1.66–3.13] |
<0.0001 |
|
| |||
| FT3 (ng/dL) | 2.99 ± 0.36 | 3.19 ± 0.2 | 0.02 |
|
| |||
| FT4 (ng/dL) | 1.08 [IQR: 1.02–1.18] |
1.17 [IQR: 1.07–1.23] |
0.01 |
|
| |||
| Total-C (mg/dL) | 204.5 ± 40.9 | 183.6 ± 31.5 | 0.02 |
|
| |||
| TG (mg/dL) | 115 [IQR: 82.7–133.2] |
98.5 [IQR: 76.7–140.7] |
0.16 |
|
| |||
| HDL-C (mg/dL) |
56.34 ± 12.06 | 56.69 ± 11.66 | 0.67 |
|
| |||
| LDL-C (mg/dL) |
134 [IQR: 110–143] |
116 [IQR: 102–136.7] |
0.08 |
|
| |||
| Lp(a) (mg/dL) | 17.55 [IQR: 12.8–53.5] |
17.85 [IQR: 15.5–38.20] |
0.86 |
|
| |||
| Excess Lp(a) percent N: (%) | N: 21 (42%) | N = 16 (28%) | 0.15 |
|
| |||
| BMI (kg/m2) | 26.64 ± 2.02 | 23.58 ± 2.72 | 0.10 |
|
| |||
| HOMA | 1.68 ± 0.58 | 1.73 ± 0.55 | 0.69 |
Normally distributed values are indicated as mean ± SD; nonnormaly distributed values are indicated as median and interquartile ranges.
TSH: thyroid stimulating hormone, FT4: free thyroxin, Total-C: total cholesterol, TG: triglyceride, HDL: high density lipoprotein, LDL: low density lipoprotein, Lp(a): lipoprotein(a), and BMI: body mass index; HOMA for insulin resistance index.
P values are the differences of subclinical hypothyroid and euthyroid Hashimoto group.